Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2021-04-07 2021-04-07
Drug Identification Number 02368552 02368552
Brand name JAMP-RISEDRONATE JAMP-RISEDRONATE
Common or Proper name Risedronate Risedronate
Company Name JAMP PHARMA CORPORATION JAMP PHARMA CORPORATION
Ingredients RISEDRONATE SODIUM RISEDRONATE SODIUM
Strength(s) 35MG 35MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 4 4
ATC code M05BA M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2019-11-01 2019-11-01
Estimated end date 2022-12-30 2022-12-30
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Supply Issues Supply Issues
Health Canada comments